← Eichor
Condition: Carcinoid Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Carcinoid Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SwissNET - a Registry for Neuroendocrine Tumours in Switzerland
Phase N/A · 55 location(s) · Insel Gruppe AG, University Hospital Bern · NCT01039922Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.
NA · 6 location(s) · Hospital Universitari de Bellvitge · NCT04735198At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Fibrosis in Chronic and Delayed Myocardial Infarction
Phase N/A · 1 location(s) · University of Edinburgh · NCT05756608Natural History of Familial Carcinoid Tumor
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00646022Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Phase 1 · 9 location(s) · RayzeBio, Inc. · NCT07165132Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
Phase 2 · 4 location(s) · Shanghai Chest Hospital · NCT07357623Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Can
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT00900419Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Phase 2 · 1 location(s) · Fox Chase Cancer Center · NCT05263050Life Following Excision of Neuroendocrine Tumors
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06981455Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GE
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04086485Pharmaceutical Management in Targeted Radioligand Therapy
Phase N/A · 3 location(s) · Hospices Civils de Lyon · NCT07389512Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT04907643Genetics of Appendix Cancer Study
Phase N/A · 1 location(s) · Andreana Holowatyj, PhD, MSCI · NCT05734430Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Phase 2 · 2 location(s) · AC Camargo Cancer Center · NCT06472388Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17
Phase 3 · 54 location(s) · RayzeBio, Inc. · NCT05477576EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
Phase 1/Phase 2 · 14 location(s) · Shanghai EpimAb Biotherapeutics Co., Ltd. · NCT05176665Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Phase 3 · 51 location(s) · Crinetics Pharmaceuticals Inc. · NCT07087054DNA Analysis of Blood and Tissue from Patients with Lung Cancer
Phase N/A · 2 location(s) · Massachusetts General Hospital · NCT00471978ALG-LungCancerRegistry (SAFRO2202)
Phase N/A · 21 location(s) · Société Algérienne de Formation et de Recherche en Oncologie · NCT07161882
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.